Mabpharm Appoints Lead Independent Director and Updates Nomination Committee
I'm PortAI, I can summarize articles.
Mabpharm Ltd. has announced changes to its management structure effective October 31, 2025. Dr. Qian Weizhu joins the nomination committee, while Mr. Tao Jing steps down. Dr. Zhang Yanyun is now the lead independent non-executive director. The updated nomination committee includes Mr. Guo Liangzhong (chairman), Dr. Zhang Yanyun, and Dr. Qian Weizhu. This announcement is for informational purposes only and should not be considered financial or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments